HUSSMAN STRATEGIC ADVISORS, INC. Corcept Therapeutics Incorporated Transaction History

HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:

$3.17M
portfolio value

HUSSMAN STRATEGIC ADVISORS, INC. quarter portfolio value change:

+7.82%
quarter

Corcept Therapeutics Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -11.11% -15.5K shares -138K $25.64 124K
Q2 2022 share Increase +168.27% 87.5K shares 2.14M $23.78 139.5K
Q1 2022 share 0.00% 0 shares 141K $22.52 52K
Q4 2021 share Decrease -66.45% -103K shares -2.02M $19.48 52K
Q3 2021 share Increase +66.67% 62K shares 1.00M $19.68 155K
Q2 2021 share Increase +29.17% 21K shares 333K $22 93K
Q1 2021 share Decrease -49.83% -71.5K shares -2.04M $23.79 72K
Q4 2020 share Decrease -43.73% -111.5K shares -684K $26.16 143.5K
Q3 2020 share Increase +41.67% 75K shares 1.41M $17.41 255K
Q2 2020 share Increase +16.88% 26K shares 1.19M $16.82 180K
Q1 2020 share Increase +50.24% 51.5K shares 591K $11.89 154K
Q4 2019 share Increase +67.22% 41.20K shares 374K $12.1 102.5K
Q3 2019 share Increase 0.00% 61.29K shares 866K $14.14 61.29K
Q3 2018 share Decrease -100.00% -125K shares -1.96M $14.02 0
Q2 2018 share Increase 0.00% 125K shares 1.96M $15.72 125K